𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Regional origin and decrease of pain in patients with depressive symptoms under treatment with venlafaxine

✍ Scribed by Stefan Begré; Martin Traber; Martin Gerber; Roland von Känel

Publisher
Springer-Verlag
Year
2009
Tongue
English
Weight
199 KB
Volume
45
Category
Article
ISSN
1433-9285

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Venlafaxine in the treatment of depressi
Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression
✍ Charlotte O. Ladd; D. Jeffrey Newport; Kimberly A. Ragan; Ada Loughhead; Zachary 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 1 views

Perimenopause is often marked by vasomotor symptoms and dysphoria. Antidepressant studies have demonstrated decreased frequency and severity of hot flashes in breast cancer survivors and menopausal women. We hypothesized that venlafaxine would relieve both depressive and vasomotor symptoms in depres

Clinical and functional outcomes in pati
Clinical and functional outcomes in patients with major depressive disorder and painful physical symptoms switched to treatment with duloxetine
✍ David V. Sheehan; Pratap R. Chokka; Renee E. Granger; Richard J. Walton; Joel Ra 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB 👁 1 views

## Objective This post hoc analysis of a multicenter, single‐arm, open‐label trial (the Attributes of Response in Depressed Patients Switched to Treatment with Duloxetine [ARDENT] study) assessed the relationship between functional improvement in the Sheehan Disability Scale (SDS) and clinical outc

Quetiapine is effective against anxiety
Quetiapine is effective against anxiety and depressive symptoms in long-term treatment of patients with schizophrenia
✍ Siegfried Kasper 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

This analysis of data from the open-label extension (OLE) phases of three randomized clinical trials of quetiapine in patients with schizophrenia (n=415) was undertaken to investigate whether the initial improvements in anxiety and depressive symptoms were maintained during long-term treatment. The

Assessment of depressive symptoms and fu
Assessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo: primary outcomes from two trials conducted under the same protocol
✍ Tina Marie Myers Oakes; Adam L. Myers; Lauren B. Marangell; Jonna Ahl; Apurva Pr 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 3 views

Objective Return of functional ability is a central goal in the treatment of major depressive disorder. We conducted two trials with the same protocol that was designed to assess functioning after 8 Weeks of treatment with duloxetine. Methods The a priori primary outcome was improvement in the Hamil